Eunsil Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eunsil Cho has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Jae-Young Koh
5 shared publications- Joo-Yong Lee
Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea
5 shared publications Jong S. Kim
3 shared publications- Mikyoung Park
Brain Science Institute, Korea Institute of Science and Technology, Seoul, South Korea
3 shared publications Joo-Yong Lee
2 shared publicationsJung-Woo Seo
2 shared publications
Latest Publications
- Open Access
- 16 October 2017
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 10, 331
Dorsal and Ventral Hippocampus Differentiate in Functional Pathways and Differentially Associate with Neurological Disease-Related Genes during Postnatal Development
The dorsal and ventral regions of the hippocampus are important in cognitive and emotional processing, respectively. Various approaches have revealed the differential molecular and structural characteristics, and functional roles of the hippocampus. Recent RNA sequencing (RNA-seq) technology has enriched our understanding of the hippocampus by elucidating more detailed information on gene expression patterns. However, no RNA-seqbased study on gene profiles in the developing hippocampus has been reported. Using RNA-seqbased bioinformatic analysis in conjunction with quantitative real-time polymerase chain reaction analysis and a comparison of in situ hybridization data obtained from the Allen Brain Atlas, we provide a thorough analysis of differentially expressed genes in the dorsal and ventral hippocampus at specific developmental ages representing the postnatally maturing hippocampus. Genes associated with particular functional pathways and marker genes for particular neurological diseases were found to be distinctively segregated within either the dorsal or ventral hippocampus at specific or at all developmental ages examined. We also report novel molecular markers enriched in the dorsal or ventral hippocampus. Taken together, this study provides insights into the molecular mechanisms underlying physiological functions linked to the dorsal or ventral hippocampus. The information provided in the study also contributes to a better understanding of brain functions and serves as a resource for future studies on the pathophysiology of dorsal and ventral hippocampal functions.
- 16 October 2017
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 10, 331
Open AccessDorsal and Ventral Hippocampus Differentiate in Functional Pathways and Differentially Associate with Neurological Disease-Related Genes during Postnatal Development
The dorsal and ventral regions of the hippocampus are important in cognitive and emotional processing, respectively. Various approaches have revealed the differential molecular and structural characteristics, and functional roles of the hippocampus. Recent RNA sequencing (RNA-seq) technology has enriched our understanding of the hippocampus by elucidating more detailed information on gene expression patterns. However, no RNA-seqbased study on gene profiles in the developing hippocampus has been reported. Using RNA-seqbased bioinformatic analysis in conjunction with quantitative real-time polymerase chain reaction analysis and a comparison of in situ hybridization data obtained from the Allen Brain Atlas, we provide a thorough analysis of differentially expressed genes in the dorsal and ventral hippocampus at specific developmental ages representing the postnatally maturing hippocampus. Genes associated with particular functional pathways and marker genes for particular neurological diseases were found to be distinctively segregated within either the dorsal or ventral hippocampus at specific or at all developmental ages examined. We also report novel molecular markers enriched in the dorsal or ventral hippocampus. Taken together, this study provides insights into the molecular mechanisms underlying physiological functions linked to the dorsal or ventral hippocampus. The information provided in the study also contributes to a better understanding of brain functions and serves as a resource for future studies on the pathophysiology of dorsal and ventral hippocampal functions.
- Open Access
- 1 September 2016
- Published by Elsevier in Pharmacological Research
- Vol. 111, 133-151
Palmitoylation in Alzheimers disease and other neurodegenerative diseases
- 1 September 2016
- Published by Elsevier in Pharmacological Research
- Vol. 111, 133-151
Open AccessPalmitoylation in Alzheimers disease and other neurodegenerative diseases
- Open Access
- 29 July 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 12624
Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP
Cyclin Y (CCNY) is a member of the cyclin protein family, known to regulate cell division in proliferating cells. Interestingly, CCNY is expressed in neurons that do not undergo cell division. Here, we report that CCNY negatively regulates long-term potentiation (LTP) of synaptic strength through inhibition of AMPA receptor trafficking. CCNY is enriched in postsynaptic fractions from rat forebrain and is localized adjacent to postsynaptic sites in dendritic spines in rat hippocampal neurons. Using live-cell imaging of a pH-sensitive AMPA receptor, we found that during LTP-inducing stimulation, CCNY inhibits AMPA receptor exocytosis in dendritic spines. Furthermore, CCNY abolishes LTP in hippocampal slices. Taken together, our findings demonstrate that CCNY inhibits plasticity-induced AMPA receptor delivery to synapses and thereby blocks LTP, identifying a novel function for CCNY in post-mitotic cells.
- 29 July 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 12624
Open AccessCyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP
Cyclin Y (CCNY) is a member of the cyclin protein family, known to regulate cell division in proliferating cells. Interestingly, CCNY is expressed in neurons that do not undergo cell division. Here, we report that CCNY negatively regulates long-term potentiation (LTP) of synaptic strength through inhibition of AMPA receptor trafficking. CCNY is enriched in postsynaptic fractions from rat forebrain and is localized adjacent to postsynaptic sites in dendritic spines in rat hippocampal neurons. Using live-cell imaging of a pH-sensitive AMPA receptor, we found that during LTP-inducing stimulation, CCNY inhibits AMPA receptor exocytosis in dendritic spines. Furthermore, CCNY abolishes LTP in hippocampal slices. Taken together, our findings demonstrate that CCNY inhibits plasticity-induced AMPA receptor delivery to synapses and thereby blocks LTP, identifying a novel function for CCNY in post-mitotic cells.
- 1 April 2012
- Published by Elsevier in Neurobiology of Disease
- Vol. 46 (1) , 215-224
Neuroprotection by urokinase plasminogen activator in the hippocampus
- 1 April 2012
- Published by Elsevier in Neurobiology of Disease
- Vol. 46 (1) , 215-224
Neuroprotection by urokinase plasminogen activator in the hippocampus
- 1 March 2012
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 71 (3) , 211-222
Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease
Synaptic vesicle Zn2+ is regulated by zinc transporter 3 (ZnT3) and is involved in neurotransmission and synaptic plasticity. Here, we describe extensive alterations of ZnT3-regulated Zn2+ pools in the brains of human amyloid precursor protein-transgenic (Tg2576) mice. In contrast to wild-type littermates in which ZnT3 expression and synaptic Zn2+ increased with age, there were age-dependent reductions in ZnT3 expression and synaptic Zn2+ levels in the hippocampal mossy fiber area of Tg2576 mice. In these mice, a novel Zn2+ pool and ZnT3 expression were colocalized and appeared along dystrophic neurites surrounding compact amyloid plaques that were identified by in situ blue fluorescence, congophilic birefringence, and Aβ42 immunoreactivity. Zn2+-specific histofluorescence and ZnT3 immunofluorescence in dystrophic neurites were also colocalized with the δ-subunit of adaptor protein complex 3, lysosome-associated membrane protein, cathepsin D, and neurofilament-containing hyperphosphorylated paired helical filaments. The synaptic vesicle marker protein synaptophysin and vesicle-associated membrane protein were not found in these neurites, suggesting a role of ZnT3 distinct from itsnormal role in synaptic Zn2+. ZnT3 immunoreactivity and Zn2+ histofluorescence were also evident in activated astrocytes. These datasuggest that extensive modifications of the cerebral Zn2+ pool, particularly synaptic Zn2+, may underlie neuronal dysfunction characteristic of Alzheimer disease.
- 1 March 2012
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 71 (3) , 211-222
Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease
Synaptic vesicle Zn2+ is regulated by zinc transporter 3 (ZnT3) and is involved in neurotransmission and synaptic plasticity. Here, we describe extensive alterations of ZnT3-regulated Zn2+ pools in the brains of human amyloid precursor protein-transgenic (Tg2576) mice. In contrast to wild-type littermates in which ZnT3 expression and synaptic Zn2+ increased with age, there were age-dependent reductions in ZnT3 expression and synaptic Zn2+ levels in the hippocampal mossy fiber area of Tg2576 mice. In these mice, a novel Zn2+ pool and ZnT3 expression were colocalized and appeared along dystrophic neurites surrounding compact amyloid plaques that were identified by in situ blue fluorescence, congophilic birefringence, and Aβ42 immunoreactivity. Zn2+-specific histofluorescence and ZnT3 immunofluorescence in dystrophic neurites were also colocalized with the δ-subunit of adaptor protein complex 3, lysosome-associated membrane protein, cathepsin D, and neurofilament-containing hyperphosphorylated paired helical filaments. The synaptic vesicle marker protein synaptophysin and vesicle-associated membrane protein were not found in these neurites, suggesting a role of ZnT3 distinct from itsnormal role in synaptic Zn2+. ZnT3 immunoreactivity and Zn2+ histofluorescence were also evident in activated astrocytes. These datasuggest that extensive modifications of the cerebral Zn2+ pool, particularly synaptic Zn2+, may underlie neuronal dysfunction characteristic of Alzheimer disease.
- 1 January 2012
- Published by Elsevier in Brain Research
- Vol. 1431, 97-106
Ibudilast, a phosphodiesterase inhibitor with anti-inflammatory activity, protects against ischemic brain injury in rats
- 1 January 2012
- Published by Elsevier in Brain Research
- Vol. 1431, 97-106
Ibudilast, a phosphodiesterase inhibitor with anti-inflammatory activity, protects against ischemic brain injury in rats
- 17 June 2010
- Published by Springer Nature in BioMetals
- Vol. 23 (6) , 1085-1095
Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain
Both apolipoprotein E (apoE) and zinc are involved in amyloid β (Aβ) aggregation and deposition, in the hallmark neuropathology of Alzheimer’s disease (AD). Recent studies have suggested that interaction of apoE with metal ions may accelerate amyloidogenesis in the brain. Here we examined the impact of apoE deficiency on the histochemically reactive zinc pool in the brains of apoE knockout mice. While there was no change in total contents of metals (zinc, copper, and iron), the level of histochemically reactive zinc (principally synaptic zinc) was significantly reduced in the apoE-deficient brain compared to wild-type. This reduction was accompanied by reduced expressions of the presynaptic zinc transporter, ZnT3, as well as of the δ-subunit of the adaptor protein complex-3 (AP3δ), which is responsible for post-translational stability and activity of ZnT3. In addition, the level of histochemically reactive zinc was also decreased in the cerebrovascular micro-vessels of apoE-deficient mice, the site of cerebral amyloid angiopathy in AD. These results suggest that apoE may affect the cerebral free zinc pool that contributes to AD pathology.
- 17 June 2010
- Published by Springer Nature in BioMetals
- Vol. 23 (6) , 1085-1095
Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain
Both apolipoprotein E (apoE) and zinc are involved in amyloid β (Aβ) aggregation and deposition, in the hallmark neuropathology of Alzheimer’s disease (AD). Recent studies have suggested that interaction of apoE with metal ions may accelerate amyloidogenesis in the brain. Here we examined the impact of apoE deficiency on the histochemically reactive zinc pool in the brains of apoE knockout mice. While there was no change in total contents of metals (zinc, copper, and iron), the level of histochemically reactive zinc (principally synaptic zinc) was significantly reduced in the apoE-deficient brain compared to wild-type. This reduction was accompanied by reduced expressions of the presynaptic zinc transporter, ZnT3, as well as of the δ-subunit of the adaptor protein complex-3 (AP3δ), which is responsible for post-translational stability and activity of ZnT3. In addition, the level of histochemically reactive zinc was also decreased in the cerebrovascular micro-vessels of apoE-deficient mice, the site of cerebral amyloid angiopathy in AD. These results suggest that apoE may affect the cerebral free zinc pool that contributes to AD pathology.
- 1 August 2009
- Published by Elsevier in Brain Research
- Vol. 1286, 208-214
Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment
- 1 August 2009
- Published by Elsevier in Brain Research
- Vol. 1286, 208-214
Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment
- 17 July 2009
- Published by Springer Nature in Neurotoxicity Research
- Vol. 17 (2) , 156-166
Endogenous Zinc Mediates Apoptotic Programmed Cell Death in the Developing Brain
Endogenous zinc can mediate the apoptotic programmed cell death (PCD) in the developing brain. Intensive accumulation of labile zinc occurs in almost all neurons undergoing PCD in the developing rat brain. Based on the greater frequency of neurons with intensive zinc accumulation compared to apoptotic neurons, it is inferred that cytosolic zinc accumulation precedes apoptotic PCD. To determine the role of intracellular labile zinc in developmental apoptosis, we subcutaneously injected the membrane-permeant zinc chelator, N,N,N′,N-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) into postnatal rats for 7 days after birth. TPEN chelated intraneuronal zinc without modulating the expression of the zinc-regulating proteins, ZnT-1, ZnT-3, and synaptophysin. The frequency of apoptotic neurons significantly decreased in TPEN-treated rat brains compared with that in normal postnatal rats. Activating cleavages of caspase-9 and -3, and mitochondrial pro-apoptotic Bax expression were reduced, whereas expression of anti-apoptotic Bcl-2 was increased. Thus, intracerebral zinc chelation may arrest PCD in the developing brain by interfering with the caspase-dependent apoptotic pathway. The present study demonstrates that intracellular zinc acts as a key mediator of developmental apoptosis and therefore provides the first in vivo evidence that endogenous labile zinc causes neuronal apoptosis.
- 17 July 2009
- Published by Springer Nature in Neurotoxicity Research
- Vol. 17 (2) , 156-166
Endogenous Zinc Mediates Apoptotic Programmed Cell Death in the Developing Brain
Endogenous zinc can mediate the apoptotic programmed cell death (PCD) in the developing brain. Intensive accumulation of labile zinc occurs in almost all neurons undergoing PCD in the developing rat brain. Based on the greater frequency of neurons with intensive zinc accumulation compared to apoptotic neurons, it is inferred that cytosolic zinc accumulation precedes apoptotic PCD. To determine the role of intracellular labile zinc in developmental apoptosis, we subcutaneously injected the membrane-permeant zinc chelator, N,N,N′,N-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) into postnatal rats for 7 days after birth. TPEN chelated intraneuronal zinc without modulating the expression of the zinc-regulating proteins, ZnT-1, ZnT-3, and synaptophysin. The frequency of apoptotic neurons significantly decreased in TPEN-treated rat brains compared with that in normal postnatal rats. Activating cleavages of caspase-9 and -3, and mitochondrial pro-apoptotic Bax expression were reduced, whereas expression of anti-apoptotic Bcl-2 was increased. Thus, intracerebral zinc chelation may arrest PCD in the developing brain by interfering with the caspase-dependent apoptotic pathway. The present study demonstrates that intracellular zinc acts as a key mediator of developmental apoptosis and therefore provides the first in vivo evidence that endogenous labile zinc causes neuronal apoptosis.
- 1 August 2007
- Published by Elsevier in Neuroscience Letters
- Vol. 423 (1) , 82-87
Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease
- 1 August 2007
- Published by Elsevier in Neuroscience Letters
- Vol. 423 (1) , 82-87
Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease